SYQUANT CAPITAL SAS Quant / Systematic

CIK: 0001766392 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Jan 8, 2020

Total Value ($000): $194,170 (100.0% shares, 0.0% debt)

Holdings (16)

AUDENTES THERAPEUTICS INC 23.7%
Value ($000) $45,927 Shares 767,502 Est. Cost $59.84 Unrealized
MEDICINES CO 22.1%
Value ($000) $42,897 Shares 505,030 Est. Cost $84.94 Unrealized
TALLGRASS ENERGY LP 11.1%
Value ($000) $21,511 Shares 972,449 Est. Cost $22.12 Unrealized
CYPRESS SEMICONDUCTOR CORP 9.4%
Value ($000) $18,256 Shares 782,500 Est. Cost $23.33 Unrealized
TECH DATA CORP 7.6%
Value ($000) $14,756 Shares 102,755 Est. Cost $143.60 Unrealized
ARQULE INC 6.4%
Value ($000) $12,371 Shares 619,800 Est. Cost $19.96 Unrealized
ALLERGAN PLC 5.5%
Value ($000) $10,610 Shares 55,500 Est. Cost $191.17 Unrealized
RA PHARMACEUTICALS INC 3.1%
Value ($000) $6,086 Shares 129,690 Est. Cost $46.93 Unrealized
TEEKAY OFFSHORE PARTNERS L P 2.4%
Value ($000) $4,693 Shares 3,047,400 Est. Cost $1.54 Unrealized
DBV TECHNOLOGIES S A 2.4%
Value ($000) $4,601 Shares 430,000 Est. Cost $10.70 Unrealized
OMNOVA SOLUTIONS INC 2.2%
Value ($000) $4,309 Shares 426,257 Est. Cost $10.07 Unrealized
WESCO AIRCRAFT HLDGS INC 2.0%
Value ($000) $3,978 Shares 360,992 Est. Cost $11.01 Unrealized
BRISTOL MYERS SQUIBB CO 1.0%
Value ($000) $1,964 Shares 652,486 Est. Cost $3.01 Unrealized
TIFFANY & CO NEW 0.7%
Value ($000) $1,443 Shares 10,800 Est. Cost $133.61 Unrealized
TERRAFORM PWR INC 0.2%
Value ($000) $391 Shares 25,400 Est. Cost $17.29 Unrealized
DIPLOMAT PHARMACY INC 0.2%
Value ($000) $377 Shares 94,260 Est. Cost $4.00 Unrealized